Opus Genetics, Inc. Cash Flow Reinvestment Rate
Opus Genetics, Inc. cash flow reinvestment rate. Opus Genetics, Inc. (IRD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $4.55 Million. Explore how well can Opus Genetics, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Opus Genetics, Inc. (2022–2022)
Cash flow reinvestment rate of Opus Genetics, Inc. from 2022 to 2022. Historical reinvestment intensity for Opus Genetics, Inc. across 1 annual periods. Also explore Opus Genetics, Inc. (IRD) net asset momentum to track the company's year-over-year net asset growth rate.
Opus Genetics, Inc. Cash Flow Reinvestment Rate by Year (2022–2022)
Opus Genetics, Inc. cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Opus Genetics, Inc.. For the full cash flow conversion analysis, see Opus Genetics, Inc. (IRD) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $14.31 Million | $0.00 | — |